In this section
MACC Fund Center for Cancer and Blood Disorders
- Programs and services
- Conditions
- Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
- Patient stories
- Locations
- Our specialists
- For medical professionals
- Contact us
- Diet and nutritional care
- Our philanthropic partners
- Get a second opinion
- Patient family information
Early stage research
Children's Wisconsin is among the top centers in the world for the treatment of pediatric cancer, with the capability and resources available to conduct early-phase (Phase I & II) clinical trials. As a member of several early-phase research consortia, Children's offers patients and families access to new, innovative treatment options. In addition, we offer several early phase studies developed by our own researchers as well as multi-center clinical trials initiated by our partners at leading programs around the country.
Spotlight on clinical trials
Some of our recent investigator-initiated clinical trials include:
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
